Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.
J Am Acad Dermatol
; 90(5): 1080-1083, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38290617
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias
/
Antineoplásicos
Tipo de estudio:
Etiology_studies
/
Observational_studies
Límite:
Humans
Idioma:
En
Revista:
J Am Acad Dermatol
/
J. Am. Acad. Dermatol
/
Journal of the American Academy of dermatology
Año:
2024
Tipo del documento:
Article